A. Petzoldt

发表

Sequential treatment with pazopanib followed by nivolumab in patients with renal cell carcinoma: Updated interim results of the non-interventional study PAZOREAL.

V. Grünwald, J. Bedke, P. Goebell, 2020 .

Sequential treatment with pazopanib (PAZO) followed by nivolumab (NIVO) in patients with advanced or metastatic renal cell carcinoma (mRCC): Third interim results of the non-interventional study PAZOREAL.

V. Grünwald, J. Bedke, P. Goebell, 2019, Journal of Clinical Oncology.